InvestorsHub Logo
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Re: None

Sunday, 08/26/2007 1:15:04 AM

Sunday, August 26, 2007 1:15:04 AM

Post# of 30387
"From the WHISPERING OAKS INTERNATIONAL INC - BOCX Annual Report

Biocurex anticipates that its serum assay, if successfully developed, will be classified as a Class II medical device."

***************************************************************
The above is from the annual report. Class two devices may be approved via a 510(k) if a predicate exists or via a PMA if a predicate does not exist.

As of a couple years ago, there has been a tightening of controls at the FDA after the Vioxx situation. No one at the FDA is going to jeopardize their career with a loose interpretation of a predicate test for RECAF. Nothing out there is similar to RECAF.

Below is a list of PMA approvals for 2004. Note the tests by Abbott and the fact that most took 180 days for approval.

http://www.fda.gov/cdrh/pma/pmafeb04.html


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.